​

Organigram Global (OGI) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

OGI Stock Rating

Organigram Global stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

OGI Price Target Upside V Benchmarks

TypeNameUpside
StockOrganigram Global-
SectorHealthcare Stocks 23.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks28.78%
IdeaCannabis Stocks List262.44%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.47$1.47$1.47
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-31--4
May, 25-41--5
Apr, 25-41--5
Mar, 25-42--6
Feb, 25-42--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 15, 2024Alliance Global PartnersBuyupgrade
Jul 15, 2022Cantor FitzgeraldOverweightOverweighthold
Apr 27, 2022Cantor FitzgeraldOverweightOverweighthold

Financial Forecast

EPS Forecast

Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported---$-2.82------
Avg Forecast$-2.19$-1.70$-0.25$-2.71$-0.42$-0.08$-0.03$0.08$0.21$0.33
High Forecast$-2.01$-1.56$-0.23$-2.56$-0.39$-0.06$-0.02$0.08$0.22$0.35
Low Forecast$-2.31$-1.80$-0.26$-2.85$-0.47$-0.09$-0.03$0.08$0.20$0.31
Surprise %---4.06%------

Revenue Forecast

$50M $120M $190M $260M $330M $400M Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported---$149.21M------
Avg Forecast$89.36M$78.54M$148.72M$155.93M$160.57M$248.12M$278.79M$302.30M$335.41M$372.63M
High Forecast$93.19M$81.91M$155.09M$164.47M$164.24M$259.64M$290.33M$306.45M$349.30M$388.05M
Low Forecast$83.70M$73.57M$139.30M$148.87M$156.99M$236.58M$267.39M$298.15M$321.70M$357.39M
Surprise %----4.31%------

Net Income Forecast

$-350M $-270M $-190M $-110M $-30M $50M Sep 20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported---$-229.48M------
Avg Forecast$-177.64M$-138.39M$-20.36M$-293.64M$-45.44M$-7.56M$-2.85M$8.65M$22.72M$35.70M
High Forecast$-163.01M$-126.99M$-18.68M$-277.94M$-42.76M$-6.41M$-2.70M$9.12M$23.94M$37.62M
Low Forecast$-187.53M$-146.09M$-21.49M$-309.34M$-50.40M$-10.08M$-3.00M$8.19M$21.51M$33.80M
Surprise %----21.85%------

OGI Forecast FAQ

Is Organigram Global stock a buy?

Organigram Global stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Organigram Global is a favorable investment for most analysts.

What is Organigram Global's price target?

Organigram Global's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.47.

How does Organigram Global stock forecast compare to its benchmarks?

Organigram Global's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the specialty & generic drug manufacturers stocks industry (28.78%), trailing the Cannabis Stocks List (262.44%) investment idea.

What is the breakdown of analyst ratings for Organigram Global over the past three months?

  • June 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Organigram Global’s EPS forecast?

Organigram Global's average annual EPS forecast for its fiscal year ending in September 2024 is $-0.42, marking a -85.11% decrease from the reported $-2.82 in 2023. Estimates for the following years are $-0.08 in 2025, $-0.03 in 2026, $0.08 in 2027, $0.21 in 2028, and $0.33 in 2029.

What is Organigram Global’s revenue forecast?

Organigram Global's average annual revenue forecast for its fiscal year ending in September 2024 is $160.57M, reflecting a 7.61% increase from the reported $149.21M in 2023. The forecast for 2025 is $248.12M, followed by $278.79M for 2026, $302.3M for 2027, $335.41M for 2028, and $372.63M for 2029.

What is Organigram Global’s net income forecast?

Organigram Global's net income forecast for the fiscal year ending in September 2024 stands at $-45.44M, representing a -80.20% decrease from the reported $-229M in 2023. Projections indicate $-7.564M in 2025, $-2.849M in 2026, $8.65M in 2027, $22.72M in 2028, and $35.7M in 2029.